About the Company
Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on PRECISION BIOSCIENCES INC
Precision BioSciences to Report First Quarter 2025 Results on ... - Nasdaq
Precision BioSciences, Inc., a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing therapies for diseases with high unmet need ...
Precision BioSciences Appoints Melinda Brown to Board of Directors
Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform.
Precision Biosciences Inc. R (PBS0.DU) - Yahoo Finance Canada
Precision BioSciences Receives U.S. FDA Fast Track Designation for PBGENE-HBV, a First-In-Class Gene Editing Therapy Designed to Eliminate the Root Cause of Chronic Hepatitis B DURHAM, N.C., April 15, ...
Precision BioSciences Reports Second Quarter 2025 Financial Results and Provides Business Update
Precision is advancing the final U.S. investigational new drug (IND)-enabling toxicology studies with an anticipated IND and/or clinical trial application (CTA) filing targeted by the end of 2025 with ...
Precision BioSciences, Inc. (NASDAQ:DTIL) Reported Earnings Last Week ...
As you might know, Precision BioSciences, Inc. (NASDAQ:DTIL) just kicked off its latest third-quarter results with some very strong numbers. Sales crushed expectations at US$7.4m, beating ...
Precision BioSciences to Report Third Quarter Results on November 7 ...
Precision BioSciences, Inc. is an advanced gene editing company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform that differs from other ...
Precision BioSciences to Participate in Upcoming August Investor ...
Precision BioSciences, Inc. is an advanced gene editing company dedicated to improving life with its novel and proprietary ARCUS® genome editing platform that differs from other technologies in ...
Precision BioSciences to Participate in the 24th Annual Needham Virtual ...
Precision BioSciences, Inc. is a clinical stage gene editing company dedicated to improving life with its novel and proprietary ARCUS ® genome editing platform that differs from other ...
Why Is Precision BioSciences Stock Soaring Today?
Precision BioSciences Inc DTIL announced the completion of a strategic transaction with Imugene Limited for global rights to Azercabtagene Zapreleucel (azer-cel), Precision's lead allogeneic CAR T ...
Similar Companies
Loading the latest forecasts...